Immunotherapy for Hepatocellular Carcinoma: New Prospects for the Cancer Therapy

Immunotherapy for Hepatocellular Carcinoma: New Prospects for the Cancer Therapy

Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related death worldwide. HCC patients may benefit from liver transplantation, hepatic resection, radiofrequency ablation, transcatheter arterial chemoembolization, and targeted therapies. The increased infiltration of immunosuppres...

Full description

Bibliographic Details
Main Authors: Rossella Fasano, Mahdi Abdoli Shadbad, Oronzo Brunetti, Antonella Argentiero, Angela Calabrese, Patrizia Nardulli, Roberto Calbi, Behzad Baradaran, Nicola Silvestris
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Life
Subjects:
hepatocellular carcinoma
tumor microenvironment
immune cells
immunotherapy
single-cell sequencing
Online Access:https://www.mdpi.com/2075-1729/11/12/1355

Internet

https://www.mdpi.com/2075-1729/11/12/1355

Similar Items